Multicenter Phase II Study of Sequential Radioembolization-Sorafenib Therapy for Inoperable Hepatocellular Carcinoma

• Pierce K. H. Chow ,

  * E-mail: pierce.chow.k.h@nccs.com.sg

  Affiliations National Cancer Centre, Singapore, Singapore, Singapore General Hospital, Singapore, Singapore, Duke-NUS Graduate Medical School, Singapore, Singapore

  ⨯
• Donald Y. H. Poon,

  Affiliation Singapore General Hospital, Singapore, Singapore

  ⨯
• Maung-Win Khin,

  Affiliation Yangon Gastrointestinal and Liver Centre, Yangon, Myanmar

  ⨯
• Harjit Singh,

  Affiliation Selayang Hospital, Selangor, Malaysia

  ⨯
• Ho-Seong Han,

  Affiliation Seoul National University Bundang Hospital, Bundang, South Korea

  ⨯
• Anthony S. W. Goh,

  Affiliation National Cancer Centre, Singapore, Singapore

  ⨯
• Su-Pin Choo,

  Affiliation Singapore General Hospital, Singapore, Singapore

  ⨯
• Hee-Kit Lai,

  Affiliation National Cancer Centre, Singapore, Singapore

  ⨯
• Richard H. G. Lo,

  Affiliation National Cancer Centre, Singapore, Singapore

  ⨯
• Kiang-Hiong Tay,

  Affiliation National Cancer Centre, Singapore, Singapore

  ⨯
• Teong-Guan Lim,

  Affiliation National Cancer Centre, Singapore, Singapore

  ⨯
• Mihir Gandhi,

  Affiliations Duke-NUS Graduate Medical School, Singapore, Singapore, Singapore Clinical Research Institute, Singapore, Singapore

  ⨯
• Say-Beng Tan,

  Affiliations Duke-NUS Graduate Medical School, Singapore, Singapore, Singapore Clinical Research Institute, Singapore, Singapore

  ⨯
• Khee-Chee Soo,

  Affiliations National Cancer Centre, Singapore, Singapore, Singapore General Hospital, Singapore, Singapore, Duke-NUS Graduate Medical School, Singapore, Singapore

  ⨯
• for the Asia-Pacific Hepatocellular Carcinoma Trials Group